SCHEMBL2321878

SCHEMBL2321878

CC(C)(C)[Si](C)(C)OCC(/C=C\C1CCCCC1)N1C(=O)c2ccccc2C1=O

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.34
▸ MAPT P10636 1/20 0.34
▸ PKM P14618 1/20 0.34
▸ HPGD P15428 1/20 0.34
▸ ALOX15 P16050 1/20 0.34
▸ ALOX12 P18054 1/20 0.34
▸ MC4R P32245 1/20 0.34
▸ HSD17B10 Q99714 1/20 0.34
▸ PDE4A P27815 5/20 0.33
▸ PDE4B Q07343 5/20 0.33
▸ PDE4C Q08493 5/20 0.33
▸ PDE4D Q08499 5/20 0.33
▸ CYP2C19 P33261 2/20 0.32
▸ CYP1A2 P05177 1/20 0.32
▸ CYP2C9 P11712 1/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.32
▸ HTT P42858 1/20 0.32
▸ TOP2A P11388 1/20 0.31
▸ KMT2A Q03164 1/20 0.30
▸ ACHE P22303 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2510637 1.00 ALDH1A1 (0.34) ALDH1A1MAPTPKMHPGDALOX15
SCHEMBL2510638 1.00 ALDH1A1 (0.34) ALDH1A1MAPTPKMHPGDALOX15
SCHEMBL2321882 1.00 ALDH1A1 (0.34) ALDH1A1MAPTPKMHPGDALOX15
SCHEMBL20040523 0.82 TDP1 (0.35) ALDH1A1MAPT
SCHEMBL12197563 0.80 ALDH1A1 (0.43) ALDH1A1MAPTPKMHPGDALOX15
SCHEMBL2507611 0.78 ALDH1A1 (0.36) ALDH1A1MAPT
SCHEMBL2507608 0.78 ALDH1A1 (0.36) ALDH1A1MAPT
SCHEMBL15320020 0.78 ALDH1A1 (0.36) ALDH1A1MAPT
SCHEMBL2511662 0.74 CDC25A (0.34) ALDH1A1CYP2C19CYP1A2CYP2C9
SCHEMBL2511661 0.74 CDC25A (0.34) ALDH1A1CYP2C19CYP1A2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2534140-B1 EFFICIENT METHODS FOR Z- OR CIS-SELECTIVE CROSS-METATHESIS TRUSTEES BOSTON COLLEGE (US) 2018-04-11 — — EP disclosed
US-8598400-B2 Efficient methods for Z- or cis-selective cross-metathesis MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2013-12-03 — — US disclosed
US-8552242-B2 — — 2013-10-08 — — US disclosed
EP-2534140-A1 EFFICIENT METHODS FOR Z- OR CIS-SELECTIVE CROSS-METATHESIS Trustees of Boston College (US) 2012-12-19 — — EP disclosed
US-20110245477-A1 EFFICIENT METHODS FOR Z- OR CIS-SELECTIVE CROSS-METATHESIS TRUSTEES OF BOSTON COLLEGE (US) 2011-10-06 — — US disclosed
WO-2011097642-A1 EFFICIENT METHODS FOR Z- OR CIS-SELECTIVE CROSS-METATHESIS TRUSTEES OF BOSTON COLLEGE (US) 2011-08-11 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110245477-A1 EFFICIENT METHODS FOR Z- OR CIS-SELECTIVE CROSS-METATHESIS PAICS, COASY, CYP51A1 ALDH1A1 701/4885MAPT 4607/4885PKM 3529/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback